Send to a Friend Share

Brean Murray Downgrades CardioNet (BEAT) to Hold; Lowers Estimates

November 9, 2009 9:25 AM EST
BEAT Hot Sheet
Rating Summary:
    0 Buy, 2 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 19 | Down: 16 | New: 82
Brean Murray downgrades CardioNet (Nasdaq: BEAT) from Buy to Hold.

Brean analyst says, "While we are long-term believers in telemetry-based monitoring platforms, we are moving to the sidelines based on lack of visibility or positive catalysts for the stock in the near-term...We are reducing FY09 and FY10 estimates to $143 million and $128 million from $149 million and $133 million...Our GAAP EPS for FY09 and FY10 are reduced to ($0.44) and ($0.85), respectively."

To see more analyst ratings on BEAT Click Here.

CardioNet, Inc. provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States.

You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Brean Murray Carret & Co.

Add Your Comment





Follow StreetInsider.com On Twitter